Cargando…
Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome
BACKGROUND: Down syndrome (DS) individuals, by the age of 40s, are at increased risk to develop Alzheimer-like dementia, with deposition in brain of senile plaques and neurofibrillary tangles. Our laboratory recently demonstrated the disturbance of PI3K/AKT/mTOR axis in DS brain, prior and after the...
Autores principales: | Tramutola, Antonella, Lanzillotta, Chiara, Barone, Eugenio, Arena, Andrea, Zuliani, Ilaria, Mosca, Luciana, Blarzino, Carla, Butterfield, D. Allan, Perluigi, Marzia, Di Domenico, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218962/ https://www.ncbi.nlm.nih.gov/pubmed/30410750 http://dx.doi.org/10.1186/s40035-018-0133-9 |
Ejemplares similares
-
Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome
por: Di Domenico, Fabio, et al.
Publicado: (2019) -
The Dysregulation of OGT/OGA Cycle Mediates Tau and APP Neuropathology in Down Syndrome
por: Zuliani, Ilaria, et al.
Publicado: (2020) -
The BACH1/Nrf2 Axis in Brain in Down Syndrome and Transition to Alzheimer Disease-Like Neuropathology and Dementia
por: Perluigi, Marzia, et al.
Publicado: (2020) -
Intranasal Administration of KYCCSRK Peptide Rescues Brain Insulin Signaling Activation and Reduces Alzheimer’s Disease-like Neuropathology in a Mouse Model for Down Syndrome
por: Tramutola, Antonella, et al.
Publicado: (2023) -
It Is All about (U)biquitin: Role of Altered Ubiquitin-Proteasome System and UCHL1 in Alzheimer Disease
por: Tramutola, Antonella, et al.
Publicado: (2016)